XML 185 R74.htm IDEA: XBRL DOCUMENT v3.24.3
Litigation (Details) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 04, 2024
Jul. 31, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2024
Sep. 30, 2023
Jul. 02, 2024
Dec. 31, 2023
Commitments and Contingencies Disclosure [Line Items]                  
Other assets     $ 20,500,000     $ 20,500,000     $ 194,300,000
Cost of goods and services sold     122,600,000 $ 176,800,000   563,300,000 $ 520,300,000    
Inventory write-offs     0 0   110,200,000 0    
Subsequent Event | Securities And Shareholder Litigation                  
Commitments and Contingencies Disclosure [Line Items]                  
Damages paid $ 40,000,000                
Damages paid from insurance proceeds $ 30,000,000                
Services                  
Commitments and Contingencies Disclosure [Line Items]                  
Revenue     13,900,000 13,200,000   96,700,000 52,200,000    
Total Bioservices revenues                  
Commitments and Contingencies Disclosure [Line Items]                  
Cost of goods and services sold     21,400,000 $ 44,300,000   263,300,000 $ 151,700,000    
Jansen Pharmaceuticals, Inc.                  
Commitments and Contingencies Disclosure [Line Items]                  
Proceeds from legal settlements   $ 50,000,000       50,000,000      
Increase in other assets         $ 152,700,000        
Other assets     $ 0     0   $ 158,700,000  
Inventory write-offs           110,200,000      
Jansen Pharmaceuticals, Inc. | Services                  
Commitments and Contingencies Disclosure [Line Items]                  
Revenue           50,000,000      
Jansen Pharmaceuticals, Inc. | Total Bioservices revenues                  
Commitments and Contingencies Disclosure [Line Items]                  
Cost of goods and services sold           $ 50,000,000